Unknown

Dataset Information

0

Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.


ABSTRACT: Promyelocytic leukemia protein nuclear bodies (PML NBs) have been implicated in host immune response to viral infection. PML NBs are targeted for degradation during reactivation of herpes viruses, suggesting that disruption of PML NB function supports this aspect of the viral life cycle. The Epstein-Barr virus (EBV) Latent Membrane Protein 1 (LMP1) has been shown to suppress EBV reactivation. Our finding that LMP1 induces PML NB immunofluorescence intensity led to the hypothesis that LMP1 may modulate PML NBs as a means of maintaining EBV latency. Increased PML protein and morphometric changes in PML NBs were observed in EBV infected alveolar epithelial cells and nasopharyngeal carcinoma cells. Treatment with low dose arsenic trioxide disrupted PML NBs, induced expression of EBV lytic proteins, and conferred ganciclovir susceptibility. This study introduces an effective modality to induce susceptibility to ganciclovir in epithelial cells with implications for the treatment of EBV associated pathologies.

SUBMITTER: Sides MD 

PROVIDER: S-EPMC3112289 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.

Sides Mark D MD   Block Gregory J GJ   Shan Bin B   Esteves Kyle C KC   Lin Zhen Z   Flemington Erik K EK   Lasky Joseph A JA  

Virology 20110524 1-2


Promyelocytic leukemia protein nuclear bodies (PML NBs) have been implicated in host immune response to viral infection. PML NBs are targeted for degradation during reactivation of herpes viruses, suggesting that disruption of PML NB function supports this aspect of the viral life cycle. The Epstein-Barr virus (EBV) Latent Membrane Protein 1 (LMP1) has been shown to suppress EBV reactivation. Our finding that LMP1 induces PML NB immunofluorescence intensity led to the hypothesis that LMP1 may mo  ...[more]

Similar Datasets

| S-EPMC2542412 | biostudies-literature
| S-EPMC9122205 | biostudies-literature
| S-EPMC3039439 | biostudies-literature
| S-EPMC3628506 | biostudies-literature
| S-EPMC3094994 | biostudies-literature
| S-EPMC11354524 | biostudies-literature
2013-03-28 | GSE40554 | GEO
| S-EPMC2441680 | biostudies-literature
| S-EPMC2663922 | biostudies-literature
| S-EPMC8066686 | biostudies-literature